1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
date : 6/28/2013
1st Series on EOL (End of life) Care discussion – Think philosophy of life and death
The discussion will investigate the issues surrounding end of life care to examine comprehensive points of view. This allows multispectral speakers to exchange their opinions in order to share the points at the issue with citizens.
Data: July 2nd (Tuesday) 19:00-21:00
Place: Tokyo 21c club (Shin-Marunouchi Build. 10F 1-5-1Marunouchi, Chiyoda-ku, Tokyo)
Organized by: Health and Global Policy Institution, NPO
Points of view: It allows multispectral speakers to exchange their opinions.
Targeted audience: Legislative body, Companies, Universities, Citizens, Mayor, Media (Reservation only)
Language: Japanese (No interpretation)
Program:
1. Discussion Point of EOL Care (Mr. Kazuhisa Takeuchi (McKinsey and Company ))
2. Philosophy of Life/Death and Community (Speaker:Yoshinori Hiroi (Professor at Chiba University, School of Law)
3. Interactive Discussion with Panelist (Seminar Proposers)
【Seminar Proposers】 (Syllabary order, Titles omitted)
– Mr. Daisuke Iwase President, Lifenet Insurance Company
– Mr. Kohei Onozaki Vice President, Corporate Affairs AstraZeneca K.K.
– Mr. Ken Shibusawa Board Chairman, Japan Center for International Exchange/ CEO of Commons Asset Management
– Mr. Kazuhisa Takeuchi McKinsey and Company
– Mr. Toshio Miyata Deputy Director of Office, Minister of Health, Labour and Welfare/ Surgeon
Exhibition date:2013-07-02
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Event Report] Planetary Health Expert Meeting Aiming for Sustainable Healthcare: Learning from the Impact of Environmental Pollution and Medical Waste During the Pandemic (February 16, 2024)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)